← Back to Search

UV Light Source

UVB treatment for Vitamin D Deficiency

N/A
Waitlist Available
Led By Michael F Holick, MD PhD
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Skin Type I-VI
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 16 of the intervention
Awards & highlights

Study Summary

This trial will test the safety and effectiveness of the Solius Photobiological System in improving serum levels of 25-hydroxyvitamin D in vitamin D deficient/ insufficient adults of various skin types.

Eligible Conditions
  • Vitamin D Deficiency

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Your skin type falls within the range of Type I-VI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Baseline serum 25-hydroxyvitamin D
Serum 25-hydroxyvitamin D at 1 week post-intervention
Serum 25-hydroxyvitamin D at 12 weeks of intervention
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: UVB treatment armExperimental Treatment1 Intervention
The treatment group will first undergo an evaluation of each individual's sensitivity to the Solius Photobiological System UVB using the device titration system for the first 5 weeks. Once determined after the 5 weeks, the subjects will be enrolled in a 16-week study where they will be exposed to their individualized titration evaluation.
Group II: Sham comparator armPlacebo Group1 Intervention
The sham comparator group will undergo the procedures as the treatment group with the exception that the Solius Photobiological System will only be turned on to emit visible radiation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
UVB treatment
2011
Completed Phase 3
~90

Find a Location

Who is running the clinical trial?

Boston UniversityLead Sponsor
451 Previous Clinical Trials
9,922,038 Total Patients Enrolled
8 Trials studying Vitamin D Deficiency
1,093 Patients Enrolled for Vitamin D Deficiency
Michael F Holick, MD PhDPrincipal InvestigatorBoston University

Media Library

Solius Photobiological System (UV Light Source) Clinical Trial Eligibility Overview. Trial Name: NCT04780776 — N/A
Vitamin D Deficiency Research Study Groups: Sham comparator arm, UVB treatment arm
Vitamin D Deficiency Clinical Trial 2023: Solius Photobiological System Highlights & Side Effects. Trial Name: NCT04780776 — N/A
Solius Photobiological System (UV Light Source) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04780776 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people still being signed up for this experiment?

"Yes, recruitment for this study is still open. According to the clinicaltrials.gov website, this trial was first posted on February 23rd, 2022 and updated as recently as October 21st of the same year."

Answered by AI

How many subjects are enrolled in the clinical trial?

"The answer is affirmative, the clinical trial in question is presently recruiting patients. The listing on clinicaltrials.gov reveals that the first posting was on February 23rd, 2022 with the most recent update being October 21st, 2022. They are seeking 100 individuals to take part in this study at a single location."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
How old are they?
18 - 65
What site did they apply to?
BU School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~17 spots leftby Mar 2025